Skip to content
Clinical Trials for Alzheimer's Disease

Anaheim, California

Alzheimer's disease clinical trials in Anaheim, CA

8 Alzheimer's disease studies are recruiting participants at sites in Anaheim as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Anaheim at a glance

  • 8 studies are recruiting at a site in Anaheim.
  • By phase: Phase 1 (2), Phase 2 (3), Phase 3 (3).
  • By sponsor: industry (8).
  • Most recent update to one of these records: November 12, 2026.

Studies recruiting in Anaheim

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Advanced Research Center, Inc.
    Registry record
    NCT05980949 · updated
  2. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT06887192 · updated
  3. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Advanced Research Center (ARC) - Anaheim
    Registry record
    NCT07011732 · updated
  4. A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

    • Phase 1
    • Ages 18 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    CenExel ACT
    Registry record
    NCT07787169 · updated
  5. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    Advanced Research Center, Inc
    Registry record
    NCT06540833 · updated
  6. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    Advanced Research Center, Inc
    Registry record
    NCT06651567 · updated
  7. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Advanced Research Center, Inc.
    Registry record
    NCT06585787 · updated
  8. A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration

    • Phase 1
    • Ages 18 to 80
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    CenExel ACT (Formerly Anaheim Clinical Trials; LLC)
    Registry record
    NCT07780383 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Anaheim, CA on ClinicalTrials.gov.

Ask about studies near Anaheim

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call